Your browser doesn't support javascript.
loading
Dupilumab improves patient-reported symptoms and health-related quality of life in children aged 6-11 years with severe atopic dermatitis.
Flohr, Carsten; Irvine, Alan D; Cork, Michael J; Simpson, Eric L; Wollenberg, Andreas; Deleuran, Mette; Praestgaard, Amy; Thomas, Ryan B; Rossi, Ana B.
Afiliação
  • Flohr C; Department of Paediatric Dermatology, St John's Institute of Dermatology, King's College London and Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Irvine AD; Clinical Medicine, Trinity College, Dublin, Ireland.
  • Cork MJ; Department of Infection, Immunity & Cardiovascular Disease, Sheffield Dermatology Research, University of Sheffield, Sheffield, UK.
  • Simpson EL; Sheffield Children's Hospital, Sheffield, UK.
  • Wollenberg A; Department of Dermatology, Oregon Health and Science University, Portland, OR, USA.
  • Deleuran M; Department of Dermatology and Allergy, Ludwig-Maximilian University, Munich, Germany.
  • Praestgaard A; Department of Dermatology, Free University Brussels, University Hospital, Brussels, Belgium.
  • Thomas RB; Aarhus University Hospital, Aarhus, Denmark.
  • Rossi AB; Sanofi, Cambridge, MA, USA.
Br J Dermatol ; 189(2): 238-240, 2023 07 17.
Article em En | MEDLINE | ID: mdl-37120724

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dermatite Atópica Tipo de estudo: Clinical_trials / Diagnostic_studies Aspecto: Patient_preference Limite: Child / Humans Idioma: En Revista: Br J Dermatol Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dermatite Atópica Tipo de estudo: Clinical_trials / Diagnostic_studies Aspecto: Patient_preference Limite: Child / Humans Idioma: En Revista: Br J Dermatol Ano de publicação: 2023 Tipo de documento: Article